Peginterferon alfa-2b vs. peginterferon alfa-2a in the treatment of hepatitis C, is there any difference?
- 作者Fernando Sierra
- 卷第46卷
- 期第2期
- 印刷ISSN0168-8278
- 文件大小61.27KB
- 发表时间2007
- DOI10.1016/j.jhep.2006.11.004
Histopathological classification of hepatocellular carcinomaMassimo Roncalli; Young Nyun Park; Luca Di Tommaso · 2010
Transarterial Therapies for Hepatocellular CarcinomaLanza, Ezio; Donadon, Matteo; Poretti, Dario; Pedicini, Vittorio; Tramarin, Marco; Roncalli, Massimo; Rhee, Hyungjin; Park, Young Nyun; Torzilli, Guido · Liver Cancer · 2017
Advanced precancerous lesions in the liverDi Tommaso, Luca; Sangiovanni, Angelo; Borzio, Mauro; Park, Young Nyun; Farinati, Fabio; Roncalli, Massimo · Best Practice & Research Clinical Gastroenterology · 2013
Large liver cell change in hepatitis B virus–related liver cirrhosisHaeryoung Kim; Bong-Kyeong Oh; Massimo Roncalli; Chanil Park; So-Mi Yoon; Jeong Eun Yoo; Young Nyun Park · 2009
The application of markers (HSP70 GPC3 and GS) in liver biopsies is useful for detection of hepatocellular carcinomaLuca Di Tommaso; Annarita Destro; Jae Yeon Seok; Emanuela Balladore; Luigi Terracciano; Angelo Sangiovanni; Massimo Iavarone; Massimo Colombo; Ja June Jang; Eunsil Yu; So Young Jin; Emanuela Morenghi; Young Nyun Park; Massimo Roncalli · 2009
VETC (vessels encapsulating tumor clusters) is a powerful predictor of aggressive hepatocellular carcinomaRenne, Salvatore Lorenzo; Woo, Ha Young; Allegra, Sarah; Rudini, Noemi; Yano, Hirohisa; Donadon, Matteo; Viganò, Luca; Akiba, Jun; Lee, Hye Sun; Rhee, Hyungjin; Park, Young Nyun; Roncalli, Massimo; Di Tommaso, Luca · Hepatology · 2019
Telomere shortening and inactivation of cell cycle checkpoints characterize human hepatocarcinogenesisRuben Raphael Plentz; Young Nyun Park; André Lechel; Haeryoung Kim; Friederike Nellessen; Britta Heike Eva Langkopf; Ludwig Wilkens; Annarita Destro; Barbara Fiamengo; Michael Peter Manns; Massimo Roncalli; Karl Lenhard Rudolph · 2007